Combination treatment of parotid salivary gland cancer
Background: Cancer of the parotid salivary gland (PSG) accounts for more than a half of all cases of salivary gland malignancies. Its treatment strategy remains a matter of debate.Aim: To identify factors significantly associated with the 3-year survival of patients with PSG cancer after combination...
Main Authors: | A. S. Balkanov, O. A. Bychenkov, A. M. Sipkin, L. E. Gaganov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2017-08-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/562 |
Similar Items
-
Our Experience in Parotid Gland Surgery: Analysis of 128 Cases
by: Bayram Veyseller, et al.
Published: (2010-03-01) -
Pediatric Pleomorphic Adenoma of the Parotid: Case Report, Review of Literature and Novel Therapeutic Targets
by: Girish Gulab Meshram, et al.
Published: (2018-09-01) -
Sialolipoma of the Parotid Gland: An Uncommon Lipoma Variant of Salivary Gland
by: Ghafar M. H. A., et al.
Published: (2018-03-01) -
Contemporary Management of Benign and Malignant Parotid Tumors
by: Jovanna Thielker, et al.
Published: (2018-05-01) -
Mucoepidermoid carcinoma of parotid gland: A case report
by: Jeetendra Purohit, et al.
Published: (2015-01-01)